Brief: SSY Group Updates On Calcium Gluconate And Sodium Chloride Injection
04/06/2025 11:24
June 4 (Reuters) - SSY Group Ltd 2005.HK: APPROVAL FOR DRUG PRODUCTION AND REGISTRATION FOR CALCIUM GLUCONATE AND SODIUM CHLORIDE INJECTION FROM NMPA OBTAINED APPROVAL FOR DRUG PRODUCTION AND REGISTRATION FOR POTASSIUM CHLORIDE GRANULES FROM NMPA Further company coverage: 2005.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on SSY
See all newsBrief: SSY Group Receives NMPA China Approval For Sodium Cromoglicate Eye Drops 2%
Brief: SSY Group Obtains NMPA Approval For Nimodipine Oral Solution
Brief: SSY Group Appoints Wu Heng Yao As Executive Director
Brief: SSY Group Says Ziprasidone Mesilate Receives Registration Approval In China
Hong Kong's SSY Group H1 profit rises on infusion solutions growth